Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial

Lignende værker

• Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
  af: Minden, Kirsten, et al.
  Udgivet: (2014)
• Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
  af: Brunner, Hermine I., et al.
  Udgivet: (2020)
• Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
  af: Kingsbury, Daniel J., et al.
  Udgivet: (2014)
• 7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
  af: Ruperto, N, et al.
  Udgivet: (2008)
• Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
  af: Lovell, Daniel J, et al.
  Udgivet: (2020)